NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/09/2021
Back to search
Official data from USPTO
ERREGIERRE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
04/09/2021
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
09/01/2008
Registration date
04/28/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/08/2019
Last transaction
05/08/2019
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
09
Owner location
SAN PAOLO D'ARGON (BG), IT
Examiner
MICHELI, ANGELA M
Law office
L10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
ERREGIERRE S.P.A.
ERREGIERRE S.P.A.
Representatives
Lawrence E. Abelman Abelman Frayne & Schwab
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for industrial purposeschemicals for use in the manufacture of principle active ingredientschemicals for use in industrychemicals for use in the biochemical and chemical industrychemicals for use in biotechnological manufacturing processeschemicals used in industry
Class 5
Antiarrhythmicsanticoagulantsanticonvulsantsantidepressantsantidiabetic preparationsantiemeticsantifungal creams for medical useantihistaminesantihypertensivesantipyretic analgesicsanti-diabetic pharmaceuticalsanti-diabetic preparationsanti-inflammatoriesanti-inflammatory and antipyretic preparationsanti-inflammatory gelsanti-inflammatory ointmentsappetite suppressantsbeta blockersbronchial dilatorsbronchodilatorscardiovascular pharmaceuticalscardiovascular treatment preparationscholesterol reducersdermatological pharmaceutical productsdermatologicalseye dropsfungicides for medical usemuscle relaxantsnausea treatment preparationsophthalmic preparationsophthalmologic preparationsophthalmological preparationspharmaceutical preparationsanticoagulantspharmaceutical preparationsantidepressantspharmaceutical preparationsappetite suppressantspharmaceutical preparations for the treatment of heart rhythm disorderspharmaceutical preparations active on the central nervous systempharmaceutical preparations and substances for the treatment of gastro-intestinal diseasespharmaceutical preparations for inhalation for the treatment of pulmonary hypertensionpharmaceutical preparations for treating allergic rhinitis and asthmapharmaceutical preparations for treating diabetespharmaceutical preparations for use in dermatologypharmaceutical preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary systemfor the treatment of inflammatory disordersfor use in dermatologyoncologyhematology and in tissue and organ transplantationin ophtalmology and for gastroenterological disorderspharmaceutical preparations for skin carepharmaceutical products for opthalmological usepharmaceutical products for treating respiratory diseases and asthmapharmaceutical skin lotionsvaginal preparationsantifungals
Class 42
Chemical analysischemical laboratorieschemical researchdevelopment of new technology for others in the field of custom synthesisdevelopment of pharmaceutical preparations and medicineslaboratory research in the field of chemistrymedical and scientific researchconducting clinical trialsmedical and scientific research in the field of medical imagingproduct developmentproduct researchproduct research and developmentresearch and development for new products for othersresearch and development of new productsresearch in the field of chemistryresearch on the subject of pharmaceuticalstestinginspection or research of pharmaceuticalscosmetics or foodstuff
Publications
History of USPTO decisions and trademark events.
27 publications found
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
01/31/2020
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
01/08/2020
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/08/2019
71AG
REGISTERED-SEC.71 ACCEPTED
05/08/2019
ES71
TEAS SECTION 71 RECEIVED
04/29/2019
RNWL
INTERNATIONAL REGISTRATION RENEWED
09/20/2018
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
04/28/2018
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
04/21/2017
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06/01/2016
INPC
INVALIDATION PROCESSED
06/01/2016
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
05/29/2016
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
09/29/2015
71AG
REGISTERED-SEC.71 ACCEPTED
09/29/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/29/2015
ES71
TEAS SECTION 71 RECEIVED
08/20/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2009
PUBO
PUBLISHED FOR OPPOSITION
02/10/2009
NPUB
NOTICE OF PUBLICATION
01/21/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/03/2009
ALIE
ASSIGNED TO LIE
01/03/2009
MAFR
APPLICATION FILING RECEIPT MAILED
12/20/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/17/2008
DOCK
ASSIGNED TO EXAMINER
12/16/2008
NWAP
NEW APPLICATION ENTERED
12/16/2008
LIMS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
12/15/2008
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/12/2008
Continuous trademark protection
Get notified about every new filing that threatens ERREGIERRE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.